e-learning
resources
Milan 2017
Monday, 11.09.2017
Does economisation of medicine transfer into benefits for patients?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Financial burden of ILD – a claims data based study
L. Schwarzkopf (Neuherberg, Germany)
Source:
International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Session:
Does economisation of medicine transfer into benefits for patients?
Session type:
Thematic Poster
Number:
2786
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Schwarzkopf (Neuherberg, Germany). Late Breaking Abstract - Financial burden of ILD – a claims data based study. 2786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Late Breaking Abstract - Assessing epidemiology and costs of asthma and COPD in Switzerland with health insurance data
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018
Late Breaking Abstract - HRQol and other health related variables of Spanish COPD patients
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Late Breaking Abstract - Microsimulation model of future trends in CF burden and demography in France
Source: International Congress 2018 – Paediatric respiratory infections: translational and clinical perspectives
Year: 2018
Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study
Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care
Year: 2017
Late Breaking Abstract - Home ventilators failure : a nation-wide cohort analysis.
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
Late Breaking Abstract: Is asthma really affecting your work? Respiratory work disability in a longitudinal population-based study
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010
Late Breaking Abstract - European prevalence of OSA in adults: Estimation using currently available data
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018
Late Breaking Abstract - Nationwide asthma management and disease control in primary versus secondary care – a real-world evidence study
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Late Breaking Abstract - The TRITRIAL COPD study: preliminary baseline patient characteristics collected during the COVID-19 pandemic
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Year: 2021
Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - Geographic accessibility and chronic respiratory disease outcomes: a decision support tool
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
Late Breaking Abstract - The effect of comorbidity on the course and outcomes of COPD in observation in the primary health care, including on the background of the COVID-19 pandemic: a comparative analysis.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Late Breaking Abstract - Cardiovascular risk and COPD in a population-based study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021
Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Late Breaking Abstract - CMV serology and COPD-related mortality: a longitudinal study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
Late Breaking Abstract - Burden of pertussis in COPD: a retrospective database study in England
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept